Antiviral therapy for chronic hepatitis B: current status and perspectives
10.3969/j.issn.1001-5256.2016.11.001
- VernacularTitle:慢性乙型肝炎抗病毒治疗现状及展望
- Author:
Rong FAN
1
;
Jian SUN
;
Jinlin HOU
Author Information
1. Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
- Publication Type:Research Article
- Keywords:
hepatitis B, chronic;
antiviral agents;
editorial
- From:
Journal of Clinical Hepatology
2016;32(11):2029-2032
- CountryChina
- Language:Chinese
-
Abstract:
Chronic hepatitis B is an important public health issue in China. The drugs used as the antiviral therapy for hepatitis B are mainly interferons and nucleos(t)ide analogues. Although these drugs have realized persistent HBV inhibition in most patients, a large number of patients cannot achieve immune control and functional cure. It is believed that in the future, with the research and development of new target drugs, we will defeat HBV in the way we defeated HCV.
